AbbVie in the UK seeks an International Market Access & Pricing lead to shape access strategies for Aquipta (atogepant) and the Menstrual Migraine indication, partnering with Area and Affiliate teams to secure pricing and reimbursement and prepare for a 2027 launch.
You will leverage clinical and health economic expertise to develop IAS, support global pricing decisions, and collaborate with IMCO, Medical Affairs, Government Affairs and other iMAP teams.
#J-18808-Ljbffr
Contact Details:
American Society for Experimental Neurotherapeutics Recruitment Team
